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(Review)
Recent trend of research on the nongenotoxic
mechanisms of chemical carcinogenesis
Kiyonori YAMAOKA, Katsumi HANAMOTO, Yasuhiro INAl), Takahiro KATAOKA2),
Atsusi KAWABE2), Masanobu SAN02) and Ayako UJIFUKU2)
Abstract
To elucidate the health effects by low dose radiation, we reviewed the recent
trend of research on the epigenetic mechanisms of chemical carcinogenesis. The
following view were obtained. It has become apparent that chemical and physical
agents that induce cancer may do so through different cellular and molecular
mechanisms. Investigators, recognizing the apparent differences in the ways com-
pounds participate in the carcinogenesis process, coined the phrases "genotoxic" and
"epigenetic" in describing activities of chemicals and physical agents that induced
cancer. The term "nongenotoxic" has to some extent replaced "epigenetic" and
thus, classification of chemical carcinogens has been frequently delegated to either
the genotoxic or nongenotoxic categories. Moreover, while much work remains in
the understanding of the modes and mechanisms of action of nongenotoxic carci-
nogens and the epigenetic effects of these agents, it is apparent that this category
of chemicals are functionally different than those compounds which directly in-
teract, mutate, and modify genomic DNA.
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